Previous Close | 0.824 |
1-Year Change | -90.57% |
6-Months Change | -85.47% |
3-Months Change | -14.43% |
Moving Avg (50d) | 0.7844 |
Moving Avg (200d) | 3.8303 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.567M |
Beta (3-Years) | 1.01 |
Revenue Growth (ttm) | 3.8% |
Net Profit Margin (ttm) | -1602.4% |
Return On Assets (ttm) | -143.34% |
EPS (ttm) | -6 |
PE Ratio (ttm) | -0.14 |
Dividend Yield | % |
Asset Description: | Helius Medical Technologies, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-09-06 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
0.863 | 0.837 | 0.819 | 0.793 | 0.749 | 0.705 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Technology |
Country: | United States |